• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDTRONIC PUERTO RICO OPERATIONS CO. INTERSTIM II; STIMULATOR, ELECTRICAL, IMPLANTABLE, FOR INCONTINENCE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDTRONIC PUERTO RICO OPERATIONS CO. INTERSTIM II; STIMULATOR, ELECTRICAL, IMPLANTABLE, FOR INCONTINENCE Back to Search Results
Model Number 3058
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Incontinence (1928); Unspecified Infection (1930); Inflammation (1932); Pain (1994); Swelling (2091); Therapeutic Response, Decreased (2271); Discomfort (2330); Complaint, Ill-Defined (2331); Sleep Dysfunction (2517)
Event Date 08/10/2020
Event Type  Injury  
Manufacturer Narrative
If information is provided in the future, a supplemental report will be issued.
 
Event Description
Information was received from a patient who was implanted with an implantable neurostimulator (ins) for urinary dysfunction/sacral nerve stim and gastrointestinal/pelvic floor therapy, overactive bladder.It was reported that the patient had to take antibiotics because there was inflammation at the implant site and it was swollen.When the inflammation went down, the lead poked out, meaning it was very visible under the surface of the skin but the skin was healed over the top of it.It was noted that when the patient bends over, it hits their pants, and is right at their waistline.The patient's doctor said it's due to the patient's lack of fatty tissue, and will stay like that. the patient also stated that it hurt 2-3 weeks after implant and they couldn't sit or sleep, but that had passed.The implant site was not bad, but the scar is tender and also puffy. they also reported that they were getting some relief from their symptoms, but last week it all changed; they were almost back to where it was prior to implant.They had urinary incontinence in a store and it ran down their leg.Troubleshooting on the call included reviewing therapy, and the patient increased amplitude from 0.5 to 0.7 and noted that they would try this first before changing programs.It was recommended that they monitor their symptoms after making the change, and make additional adjustments based on their symptom results.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
INTERSTIM II
Type of Device
STIMULATOR, ELECTRICAL, IMPLANTABLE, FOR INCONTINENCE
Manufacturer (Section D)
MEDTRONIC PUERTO RICO OPERATIONS CO.
road 31, km. 24, hm 4
ceiba norte industrial park
juncos PR 00777
Manufacturer (Section G)
MEDTRONIC PUERTO RICO OPERATIONS CO.
road 31, km. 24, hm 4
ceiba norte industrial park
juncos PR 00777
Manufacturer Contact
david gustafson
7000 central avenue ne rcw215
minneapolis, MN 55432
7635149628
MDR Report Key10685501
MDR Text Key211653003
Report Number3004209178-2020-18039
Device Sequence Number1
Product Code EZW
UDI-Device Identifier00613994913654
UDI-Public00613994913654
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P970004
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type consumer
Reporter Occupation Non-Healthcare Professional
Type of Report Initial
Report Date 10/15/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date08/14/2020
Device Model Number3058
Device Catalogue Number3058
Was Device Available for Evaluation? No
Initial Date Manufacturer Received 10/12/2020
Initial Date FDA Received10/15/2020
Date Device Manufactured02/25/2019
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age47 YR
Patient Weight64
-
-